Sirona Biochem CEO Letter to Shareholders
Sirona Biochem Reports 100% Safety in First Tox Study for Increased Concentration of TFC-1067
Sirona Biochem Proceeds to First Clinical Tests for Higher Concentrations to Increase Commercial Value of Skin Lightening Compound TFC-1067
Sirona Biochem Hires Shanghai-based Chemistry Engineer to Select Local Manufacturer for Skin-Lightening Compound TFC-1067
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 59
- Next Page »